HYBR-012
N/A
Report date: 2026/05/12 20:00:17
Base Information
Drug NameHYBR-012
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Benemae Pharmaceutical Co
China Registration ClassN/A
Develop Information
Active CompaniesShanghai Benemae Pharmaceutical Co
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A